Dashboard
Alnylam Pharmaceuticals, Inc.
ALNYNASDAQFor informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.
Universal block
Live market data + trailing fundamentals.
Recent events
Material filings, federal awards, and regulatory activity. Impact is scored against market cap.
- Nov 17Ownership changeSEC
Form 4 insider transaction filing dated 2026-11-17.
- Nov 12Ownership changeSEC
SEC Form 4 insider transaction filing.
- Nov 12Ownership changeSEC
Form 4 insider ownership change filing.
- Nov 12Ownership changeSEC
Form 4 insider transaction filing.
- Nov 5LeadershipSEC
8-K filed with items 5.02 and 8.01 on 2026-11-05 regarding director or officer matters.
- Oct 29Financial resultsSEC
Alnylam filed 8-K (items 2.02, 9.01) reporting financial results.
- Oct 6Ownership changeSEC
SEC Form 4 insider transaction filing.
- Sep 22OtherSEC
SEC Form 4 insider transaction filing.
- Jul 30Financial resultsSEC
Filed 8-K (items 2.02, 9.01) disclosing results of operations and financial condition.
- Jun 3Ownership changeSEC
Form 4 filing reporting change in beneficial ownership by an insider at Alnylam Pharmaceuticals.
- Jun 3Ownership changeSEC
SEC Form 4 insider transaction filing
- May 27LeadershipSEC
8-K (items 5.02, 5.07) reports officer/director changes and shareholder vote results from 2026-05-20 meeting.
- May 22Ownership changeSEC
SEC Form 4 insider ownership filing.
- May 22Ownership changeSEC
SEC Form 4 insider ownership filing.
- May 22Ownership changeSEC
Form 4 insider ownership filing
- May 22Ownership changeSEC
SEC Form 4 insider transaction filing.
- May 22Ownership changeSEC
SEC Form 4 filing reporting change in beneficial ownership by insider.
- May 22Ownership changeSEC
SEC Form 4 insider transaction filing.
- May 22Ownership changeSEC
SEC Form 4 filed reporting change in beneficial ownership.
- May 22Ownership changeSEC
SEC Form 4 insider transaction filing.
Not financial advice — research and opinion only. Disclosures